Millennium: Blood-cancer drug trial yields positive results

03/14/2008 | Boston Globe (tiered subscription model), The

A drug cocktail composed of melphalan, prednisone and Velcade that was given to multiple myeloma patients resulted in high rates of complete remission and three-year survival, Millennium Pharmaceuticals reports. Developed by Millennium and Johnson & Johnson, Velcade is already approved for use in multiple myeloma patients who have undergone at least one prior treatment. The combination trial was in newly diagnosed patients deemed ineligible for stem cell transplants.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA